Breaking News Instant updates and real-time market news.

MBRX

Moleculin Biotech

$1.14

0.085 (8.10%)

07:38
01/03/19
01/03
07:38
01/03/19
07:38

Moleculin Biotech announces preliminary WP1732 data

Moleculin Biotech announced that in preliminary animal studies, a second of its lead drugs, WP1732, has demonstrated enhanced activity in combination with checkpoint blockade antibodies in pancreatic cancer. "After our sponsored research demonstrated that WP1066 was able to enhance immune checkpoint activity in a pancreatic cancer animal model," commented Walter Klemp, Moleculin's chairman and CEO. "We were optimistic that we could show similar potential results in our water soluble, WP1732 drug candidate. This is significant for several reasons. It shows that this is a consistent capability across our platform of STAT3 inhibitors and it further supports independent research suggesting that STAT3 may be a key to enabling checkpoint blockade activity in otherwise resistant tumors. Importantly, though, when you couple this with our recent findings that WP1732 accumulates disproportionately in the pancreas, we believe it points to WP1732 as a potentially pivotal new approach to treating pancreatic cancer. Expansion of the WP1732 and WP1066 in vivo studies is in progress."

MBRX Moleculin Biotech
$1.14

0.085 (8.10%)

11/14/18
MAXM
11/14/18
INITIATION
Target $3
MAXM
Buy
Moleculin Biotech initiated with a Buy at Maxim
As reported earlier, Maxim analyst Jason McCarthy initiated Moleculin Biotech with a Buy rating and a price target of $3. The analyst cites the company's three differentiated cancer programs - STAT3 inhibition in brain tumors with WP1066, chemotherapy with Annamycin in leukemia patients, and the WP1122 targeting of cancer metabolism by slowing its progression through starving it of glucose. McCarthy is hopeful that Moleculin's ongoing and upcoming trials, followed by their data readouts, demonstrate proof-of-concept in these indications and generate catalysts for the stock's higher valuation.
11/14/18
MAXM
11/14/18
INITIATION
Target $3
MAXM
Buy
Moleculin Biotech initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

AWRE

Aware

$2.93

(0.00%)

11:07
11/19/19
11/19
11:07
11/19/19
11:07
Hot Stocks
Aware appoints Mohamed Lazzouni as CTO »

Aware announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:06
11/19/19
11/19
11:06
11/19/19
11:06
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

11:06
11/19/19
11/19
11:06
11/19/19
11:06
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

MDCO

The Medicines Co.

$69.90

11.24 (19.16%)

, NVS

Novartis

$90.20

-0.08 (-0.09%)

11:06
11/19/19
11/19
11:06
11/19/19
11:06
Recommendations
The Medicines Co., Novartis analyst commentary  »

JPMorgan says Medicines…

MDCO

The Medicines Co.

$69.90

11.24 (19.16%)

NVS

Novartis

$90.20

-0.08 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PDD

Pinduoduo

$40.14

-1.41 (-3.39%)

11:05
11/19/19
11/19
11:05
11/19/19
11:05
Options
Pinduoduo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VRTX

Vertex

$213.24

3.23 (1.54%)

, CRSP

Crispr Therapeutics

$72.97

14.45 (24.69%)

11:03
11/19/19
11/19
11:03
11/19/19
11:03
Recommendations
Vertex, Crispr Therapeutics analyst commentary  »

Cantor boosts Vertex…

VRTX

Vertex

$213.24

3.23 (1.54%)

CRSP

Crispr Therapeutics

$72.97

14.45 (24.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 19

    Mar

W

Wayfair

$84.93

-1.5 (-1.74%)

, AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

10:57
11/19/19
11/19
10:57
11/19/19
10:57
Periodicals
Citron accuses Wayfair of lying, says shares headed to $45 »

Andrew Left's Citron…

W

Wayfair

$84.93

-1.5 (-1.74%)

AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

RH

RH

$181.50

-6.08 (-3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 19

    Dec

MCS

Marcus

$33.79

0.305 (0.91%)

10:57
11/19/19
11/19
10:57
11/19/19
10:57
Conference/Events
Benchmark services/entertainment analysts hold analyst/industry conference call »

Consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

SPY

SPDR S&P 500 ETF Trust

$311.90

-0.11 (-0.04%)

10:50
11/19/19
11/19
10:50
11/19/19
10:50
Options
Massive collar trade in SPY tied to 4M shares suggests sentiment shift »

Massive collar trade in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
11/19/19
11/19
10:50
11/19/19
10:50
General news
Treasury Action: yields are extending lower as stocks sag »

Treasury Action: yields…

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Hot Stocks
Breaking Hot Stocks news story on Wayfair »

Wayfair shares down 2% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Periodicals
Breaking Periodicals news story on Wayfair »

Citron Research puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Periodicals
Breaking Periodicals news story on Wayfair »

Citron Research puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CDE

Coeur Mining

$6.69

0.055 (0.83%)

10:45
11/19/19
11/19
10:45
11/19/19
10:45
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/19/19
11/19
10:45
11/19/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/19/19
11/19
10:45
11/19/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:40
11/19/19
11/19
10:40
11/19/19
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

HCM

Hutchison China MediTech

$23.59

(0.00%)

10:33
11/19/19
11/19
10:33
11/19/19
10:33
Initiation
Hutchison China MediTech initiated  »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$35.16

-2.72 (-7.18%)

10:30
11/19/19
11/19
10:30
11/19/19
10:30
Options
Selloff in Nordstrom's prompts vertical put spread to roll position »

Selloff in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 05

    Dec

HOG

Harley-Davidson

$37.03

-0.535 (-1.42%)

10:28
11/19/19
11/19
10:28
11/19/19
10:28
Conference/Events
UBS leisure/finance analysts to hold an analyst/industry conference call »

Leisure Analyst Farley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$59.41

-0.05 (-0.08%)

10:27
11/19/19
11/19
10:27
11/19/19
10:27
Periodicals
Cornerstone OnDemand a candidate for activist pressure, Dealreporter says »

Cornerstone OnDemand,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

NCR

NCR Corp.

$33.52

-0.08 (-0.24%)

10:25
11/19/19
11/19
10:25
11/19/19
10:25
Conference/Events
NCR Corp. management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

TLRY

Tilray

$20.11

0.23 (1.16%)

10:25
11/19/19
11/19
10:25
11/19/19
10:25
Options
Tilray call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$60.85

1.31 (2.20%)

10:24
11/19/19
11/19
10:24
11/19/19
10:24
Recommendations
TJX analyst commentary  »

TJX reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

NCR

NCR Corp.

$33.54

-0.06 (-0.18%)

10:24
11/19/19
11/19
10:24
11/19/19
10:24
Conference/Events
NCR Corp. management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.